Cargando…

Plasma Exchange in Patients With Myositis due to Immune Checkpoint Inhibitor Therapy

Immune checkpoint inhibitors used to treat malignancies may lead to various immune-related adverse events (irAEs) including conditions such as myositis and myasthenia gravis (MG). Here, we describe 2 cases of myositis treated effectively with therapeutic plasma exchange (PLEX). A 64-year-old man wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Katyal, Nakul, Katsumoto, Tamiko R., Ramachandran, Kavitha J., Yunce, Muharrem, Muppidi, Srikanth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Journal of Clinical Neuromuscular Disease 2023
Materias:	Short Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10645099/ https://www.ncbi.nlm.nih.gov/pubmed/37962196 http://dx.doi.org/10.1097/CND.0000000000000457

Ejemplares similares

Plasma exchange for severe immune-related adverse events from checkpoint inhibitors: an early window of opportunity?
por: Katsumoto, Tamiko R, et al.
Publicado: (2022)

Plasma Exchange for Immune Checkpoint Inhibitor–Induced Myocarditis
por: Yogasundaram, Haran, et al.
Publicado: (2020)

Immune Checkpoint Inhibitor-Related Myositis: From Biology to Bedside
por: Solimando, Antonio G., et al.
Publicado: (2020)

Tropomyosin autoantibodies associated with checkpoint inhibitor myositis
por: Zaenker, Pauline, et al.
Publicado: (2020)

Myasthenia gravis and concurrent myositis following PD-L1 checkpoint inhibitor for non-small cell lung cancer
por: Phua, Chun Seng, et al.
Publicado: (2020)

Myocarditis-myositis-myasthenia gravis overlap syndrome depending on immune checkpoint inhibitor
por: Ünlütürk, Zeynep, et al.
Publicado: (2023)

Checkpoint inhibitor induced myositis – The value of MRI STIR
por: Erritzøe-Jervild, Mai, et al.
Publicado: (2023)

Chronic immune checkpoint inhibitor pneumonitis
por: Naidoo, Jarushka, et al.
Publicado: (2020)

Value of troponin T versus I in the diagnosis of immune checkpoint inhibitor‐related myocarditis and myositis: rechallenge?
por: Rossi, Valentina A., et al.
Publicado: (2023)

Efficacy of immune checkpoint inhibitors for in-transit melanoma
por: Nan Tie, Emilia, et al.
Publicado: (2020)

Rituximab in Refractory Myositis and Acute Neuropathy Secondary to Checkpoint Inhibitor Therapy
por: Jain, Varun, et al.
Publicado: (2022)

Intravascular large B-cell lymphoma presenting as multiple stroke: A case report
por: Yunce, Muharrem, et al.
Publicado: (2018)

Immune checkpoint inhibitor induced myocarditis, myasthenia gravis, and myositis: A single‐center case series
por: Longinow, Joshua, et al.
Publicado: (2022)

Acute interstitial nephritis related to immune checkpoint inhibitors
por: Belliere, Julie, et al.
Publicado: (2016)

Isolated Neutropenia Due to Immune Checkpoint Inhibitors
por: Jalil, Ahmad, et al.
Publicado: (2023)

Fatal myositis and spontaneous haematoma induced by combined immune checkpoint inhibitor treatment in a patient with pancreatic adenocarcinoma
por: Liu, Yuan, et al.
Publicado: (2019)

Immune Checkpoint Inhibitor-Related Myositis Overlapping With Myocarditis: An Institutional Case Series and a Systematic Review of Literature
por: Nakagomi, Yuki, et al.
Publicado: (2022)

Immune checkpoint inhibitor-induced myocarditis and myositis in liver cancer patients: A case report and literature review
por: Mei, Haoran, et al.
Publicado: (2023)

Incidence and Distinct Features of Immune Checkpoint Inhibitor-Related Myositis From Idiopathic Inflammatory Myositis: A Single-Center Experience With Systematic Literature Review and Meta-Analysis
por: Hamada, Naoki, et al.
Publicado: (2021)

Immune Checkpoint Inhibition–Related Myasthenia-Myositis-Myocarditis Responsive to Complement Blockade
por: Nelke, Christopher, et al.
Publicado: (2023)

Herpes hepatitis as a complication of total abdominal hysterectomy; an unusual complication of abdominal instrumentation
por: Yunce, Muharrem, et al.
Publicado: (2018)

Myositis due to COVID-19
por: Uslu, Sadettin
Publicado: (2021)

Case report of elevation of high-sensitivity cardiac troponin T in the absence of cardiac involvement in immune checkpoint inhibitor-associated myositis
por: Ruperti-Repilado, Francisco Javier, et al.
Publicado: (2022)

Immune checkpoint inhibitor lichenoid eruption due to pembrolizumab
por: McCormick, Benjamin Joseph, et al.
Publicado: (2023)

Nephrotoxicity of immune checkpoint inhibitors beyond tubulointerstitial nephritis: single-center experience
por: Mamlouk, Omar, et al.
Publicado: (2019)

Primary malignant melanoma of the lung: a case report of a rare tumor and review of the literature
por: Yunce, Muharrem, et al.
Publicado: (2018)

Conditional immune toxicity rate in patients with metastatic renal and urothelial cancer treated with immune checkpoint inhibitors
por: Nuzzo, Pier Vitale, et al.
Publicado: (2020)

Inclusion body myositis associated with Sjögren’s syndrome
por: Misterska-Skóra, Maria, et al.
Publicado: (2012)

Impact of corticosteroid therapy on the outcomes of hepatocellular carcinoma treated with immune checkpoint inhibitor therapy
por: Pinato, David J, et al.
Publicado: (2020)

Risk factors for cancer-associated thrombosis in patients undergoing treatment with immune checkpoint inhibitors
por: Ando, Yosuke, et al.
Publicado: (2019)

Immune manifestations with checkpoint inhibitors in a single Brazilian center: experience and literature review
por: Schmerling, Rafael A, et al.
Publicado: (2020)

Thyroid Dysfunctions Due to Immune Checkpoint Inhibitors: A Review
por: El Sabbagh, Rawaa, et al.
Publicado: (2020)

Concurrent therapy with immune checkpoint inhibitors and TNFα blockade in patients with gastrointestinal immune-related adverse events
por: Badran, Yousef R., et al.
Publicado: (2019)

Eosinophilic myositis in a slaughtered Korean native cattle
por: Do, Sun Hee, et al.
Publicado: (2008)

Concomitant myasthenia gravis, myositis, myocarditis and polyneuropathy, induced by immune-checkpoint inhibitors: A life–threatening continuum of neuromuscular and cardiac toxicity
por: Rota, Eugenia, et al.
Publicado: (2018)

Immune Checkpoint Inhibitor-Induced Myositis/Myocarditis with Myasthenia Gravis-like Misleading Presentation: A Case Series in Intensive Care Unit
por: Deharo, François, et al.
Publicado: (2022)

Potential clinical and immunotherapeutic utility of talimogene laherparepvec for patients with melanoma after disease progression on immune checkpoint inhibitors and BRAF inhibitors
por: Chesney, Jason, et al.
Publicado: (2018)

Immune checkpoint blockade in ovarian cancer
por: Weiss, Lukas, et al.
Publicado: (2016)

Efficacy and safety of immune checkpoint inhibitor monotherapy in elderly patients with non‐small cell lung cancer
por: Chikaishi, Yasuhiro, et al.
Publicado: (2021)

Case Report: The Neuromusclar Triad of Immune Checkpoint Inhibitors: A Case Report of Myositis, Myocarditis, and Myasthenia Gravis Overlap Following Toripalimab Treatment
por: Luo, Yue-Bei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_leanughqcc34ioqb7l6qb0br9r